InvestorsHub Logo

Ultimate01

05/02/15 8:55 AM

#100235 RE: John B #100230

"only BRI demonstrated a 99.9% reduction compared to baseline"

AWESOME!!!


GO BRILACIDIN!!!

frrol

05/02/15 8:57 AM

#100236 RE: John B #100230

Thanks, we saw this already. Seems B has trouble penetrating the corneal surface, which is going to limit its ophthalmic use.